Phenobenzylamine hydrochloride side effects include carcinogenicity, gastrointestinal reactions, circulatory system reactions and so on.
1. Carcinogenicity: Animal experiments show that phenobenzylamine hydrochloride is carcinogenic: continuous intraperitoneal injection of phenobenzylamine hydrochloride in rats or mice can cause peritoneal sarcoma; long-term oral administration in rats can cause gastrointestinal malignant tumors, which is related to the action of the drug.
2. Gastrointestinal reactions: drug stimulation of gastrointestinal tract can cause nausea, vomiting and other gastrointestinal reactions.
3. Circulatory system reaction: long-term medication or overdose of the drug can cause postural hypotension, fatigue, tachycardia, drowsiness, shock, dry mouth, shrinking pupils and blurred vision, lethargy, headache, drowsiness and so on.
The drug is contraindicated in hypotension, angina pectoris, myocardial infarction, hypersensitivity to phenobenzylamine hydrochloride and its components. It should be noted that during the use of the drug it is necessary to regularly measure blood pressure, when starting treatment of pheochromocytoma, it is recommended to regularly measure urinary catecholamines and their metabolites in order to determine the dosage of the drug.
The use of the drug may lead to toxic side effects, etc., which may easily cause the occurrence of damage other than the treatment of the disease, and it is recommended to take the drug in strict accordance with the rules and regulations after consulting with a professional doctor in a regular hospital.